Sonic Healthcare Limited
SKHHY
Other OTC13.49
USD
-0.21
- -
ISIN
US83546A2033
CUSIP
83546A203
Return %
Stock
S&P500
1Y
-21.93
26.84
3Y
-43.51
77.03
5Y
-49.68
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- James Pacey Newcombe
- Full Time Employees
- 42,000
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- Grosvenor Place Sydney NSW Australia 2000
- IPO Date
- Oct 25, 2010
- Website
- sonichealthcare.com
- Similar Companies
- Business
- Sonic Healthcare Limited is a global provider of medical diagnostic services headquartered in Sydney, Australia. The company operates primarily in the laboratory medicine, pathology, radiology, and primary care sectors. Its core product offerings include pathology and clinical laboratory services; diagnostic imaging and radiology services; medical center operations under its Independent Practitioner Network (IPN) brand; and occupational health services provided through its Sonic HealthPlus division. Sonic Healthcare's laboratory services span Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, and Belgium. Its radiology services are delivered mainly in Australia, while the Other segment encompasses corporate office functions, healthcare centers, and occupational health services. Founded in 1978, Sonic Healthcare has grown into one of the largest private pathology operators globally, with approximately 42,000 employees and annual revenue of around AUD 9.65 billion as of the 2025 financial year. The company is the largest private pathology operator in Australia, Germany, Switzerland, and the UK; the second-largest in Belgium and New Zealand; and the third-largest in the United States. The company serves a diverse customer base including hospitals, medical practitioners, and occupational health sectors, leveraging its broad geographic footprint to deliver diagnostic and healthcare services. Recent major changes include strategic acquisitions and partnerships that expand its diagnostic and healthcare footprint. In the past two years, Sonic Healthcare has continued growth through acquisitions of pathology and radiology practices, including expansions in the US market with the acquisition of ProPath in Dallas, Texas, and further development of its medical imaging capabilities in Australia with a majority stake acquisition in Epworth Medical Imaging. The company has also pursued strategic partnerships with US health systems such as Baptist Memorial Health Care and NYU Health System to enhance specialized diagnostic services. Additionally, Sonic Healthcare has integrated new digital pathology solutions through investments in artificial intelligence-based pathology services via its acquisition of a stake in Harrison.ai. These moves reflect Sonic Healthcare's strategic focus on expanding its comprehensive diagnostic services and leveraging technology for improved healthcare delivery. Sonic Healthcare operates in the healthcare diagnostics industry, serving hospitals, healthcare providers, corporate clients, and patients across multiple countries, including Australia, New Zealand, the US, UK, Germany, Switzerland, Belgium, and Ireland. The company is publicly listed on the Australian Securities Exchange (ASX) under the ticker SKHHY. Its latest financial reporting shows steady revenue growth, driven mainly by its laboratory services segment, which contributes approximately 85% of total revenue, complemented by growth in radiology and other healthcare services. Sonic Healthcare maintains a broad presence through its subsidiaries and partnerships across key international markets, positioning itself as a leading global diagnostic services provider focused on delivering high-quality pathology, radiology, and primary healthcare services with ongoing innovations and strategic market expansions in recent years.
Critical Contrast: Ethema Health (OTCMKTS:GRST) & Sonic Healthcare (OTCMKTS:SKHHY)
Sonic Healthcare (OTCMKTS:SKHHY) Shares Pass Below 200 Day Moving Average – Here’s What Happened
CochLear (OTCMKTS:CHEOY) and Sonic Healthcare (OTCMKTS:SKHHY) Financial Review
Sonic Healthcare (OTCMKTS:SKHHY) and Amplifon (OTCMKTS:AMFPF) Critical Survey
Sonic Healthcare Limited (SKHHY) Q2 2026 Earnings Call Transcript
Sonic Healthcare (OTCMKTS:SKHHY) Shares Gap Up – Time to Buy?
Sonic Healthcare (OTCMKTS:SKHHY) Shares Gap Down – Should You Sell?
Sonic Healthcare Limited (SKHHY) Shareholder/Analyst Call Transcript
Comparing Sonic Healthcare (OTCMKTS:SKHHY) & InnovAge (NASDAQ:INNV)
All You Need to Know About Sonic Healthcare Ltd. Sponsored ADR (SKHHY) Rating Upgrade to Buy
Sonic Healthcare Limited (SKHCF) Q4 2025 Earnings Call Transcript
Sonic Healthcare Limited (SKHCF) Q2 2025 Earnings Call Transcript
Sonic Healthcare Limited (SKHCF) Q2 2024 Earnings Call Transcript